Filter
2199
Filtered Results: 2199
Text search:
J.
King
Featured
Recommendations
180
New Publications
382
Language
Document type
No document type
1057
Studies & Reports
561
Guidelines
316
Manuals
131
Strategic & Response Plan
53
Fact sheets
33
Training Material
30
Situation Updates
7
Infographics
7
Brochures
2
Resource Platforms
2
Countries / Regions
Global
116
Western and Central Europe
80
India
41
South Africa
39
Africa
34
Kenya
33
Russia
31
Ukraine
28
Sierra Leone
27
Eastern Europe
27
Nepal
26
Nigeria
24
Uganda
24
Latin America and the Carribbean
24
Eastern Europe and Central Asia
22
Brazil
21
Liberia
19
Zambia
19
Asia
18
Congo, Democratic Republic of
17
Syria
17
Malawi
17
Germany
16
Tanzania
16
Mozambique
16
Myanmar / Burma
15
Rwanda
14
Middle East and North Africa
14
Ethiopia
13
Lesotho
12
South–East Asia Region
12
West and Central Africa
11
Bangladesh
10
Guinea
9
Cameroon
9
Zimbabwe
9
Cambodia
9
Indonesia
9
Senegal
8
Ghana
8
South Sudan
8
Yemen
8
Burkina Faso
7
Eswatini/ Swaziland
7
Haiti
6
East and Southern Africa
6
Kyrgyzstan
6
Lebanon
5
Thailand
5
Sudan
5
Angola
5
Paraguay
5
Vietnam
5
United Kingdom
5
Spain
5
Philippines
4
Pakistan
4
China
4
Argentina
4
Peru
4
North Macedonia
4
Madagascar
4
Albania
4
Tajikistan
4
Portugal
4
Côte d’Ivoire / Ivory Coast
3
Jordan
3
Chad
3
Benin
3
Colombia
3
Sri Lanka
3
Chile
3
Southern Africa
3
Estonia
3
Kazakhstan
3
Georgia
3
North America
3
Jamaica
3
Guinea-Bissau
2
Morocco
2
USA
2
Saudi Arabia
2
Iraq
2
Turkey
2
Ecuador
2
Botswana
2
Mexico
2
Western Pacific Region
2
Italy
2
Canada
2
Moldova
2
France
2
Belarus
2
Bosnia and Herzegovina
2
Mali
1
Somalia
1
Afghanistan
1
Papua New Guinea
1
Central African Republic
1
Hungary
1
Burundi
1
El Salvador
1
Bolivia
1
Greece
1
Guatemala
1
Venezuela
1
Armenia
1
Mongolia
1
Laos
1
Qatar
1
Lithuania
1
Iran
1
Turkmenistan
1
Japan
1
Denmark
1
Belgium
1
Tunisia
1
Norway
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
487
Clinical Guidelines
232
Public Health
163
Women & Child Health
110
Key Resources
73
Pharmacy & Technologies
29
Capacity Building
23
Toolboxes
Mental Health
285
COVID-19
216
HIV
194
Planetary Health
139
TB
106
NCDs
79
Caregiver
76
NTDs
73
Disability
69
AMR
65
Rapid Response
55
Ebola
45
Health Financing Toolbox
44
Global Health Education
41
Conflict
40
Refugee
39
Pharmacy
39
Social Ethics
18
Specific Hazards
17
Natural Hazards
11
Polio
10
Zika
10
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
Monitoring financial protection and utilization of health services in Mongolia 2009-2018 is based on national representative household socioeconomic surveys. The study finds that between 2009 and 2018, despite ambitious health reforms, the incidence of catastrophic health spending and impoverishing ...
Schools are generally the most popular setting for drug-use-
prevention programmes, and are used both by governmental and
non-governmental agencies. This may be for many reasons: ease of
obtaining funding for school drug-use-prevention programmes, the
captive audience, and the popular perception...
Sector Environmental Guidelines, Full technical Update
This policy brief aims to provide a review of the current progress on implementing the Kenya national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing ac...
Lymphatic filariasis is a neglected tropical disease that can cause permanent disability through disruption of the lymphatic system. This disease is caused by parasitic filarial worms that are transmitted by mosquitos. Mass drug administration (MDA) of antihelmintics is recommended by WHO to elimina...
As part of the UN’s data strategy—which seeks to nurture data as a strategic asset for insight, impact and integrity—UNAIDS plays an indispensable role in generating data for effective action against the AIDS pandemic. It leads the
world’s most extensive data collection on HIV epidemiology,...
Although Shiga toxin-producing Escherichia coli (STEC) have been isolated from a variety of food production animals, they are most commonly associated with ruminants from which we derive meat and milk. Because of the widespread and diverse nature of ruminant-derived food production, coupled with the...
Globally, more than 3 million new cases and 10 000 deaths have been reported in the week of 26 December 2022 to 1 January 2023. This represents a reduction in weekly cases and deaths of 22% and 12%, respectively. In the last 28 days (5 December 2022 to 1 January 2023), over 14.5 million cases and ov...
Since 1996, trachoma has been targeted for elimination as a public health problem worldwide. The active trachoma criterion for national elimination as a public health problem is a TF1–9 < 5%, sustained for at least two years in the absence of antibiotic mass drug administration (MDA), in each form...
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads to trichiasis with or without entropion. The abrasive action of eyelashes can
d...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci...
This new guidance aims to support programme implementers, coordinators and others in humanitarian settings in their actions to counter suicide and self-harm in humanitarian contexts and to save lives.
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t...
This thematic brief accompanies the Working for Health 2022–2030 Action Plan, serving as a rationale to the related actions of the Working for Health progression model (see Annex). The brief aims to inform Member States, non-state actors and other users of the Action Plan to guide action on inves...
This training module is designed to equip health workers (HWs) with
knowledge, skills, confidence and resources to help them in their role to recommend the Human Papillomavirus
(HPV) vaccine.
This document provides an overview of strategic purchasing of nutrition services within primary health care. It introduces key terms and payment methods for countries to use in preparing to transform their health financial systems to scale up nutrition services. It does so by introducing nutritional...
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings and is caused by two subspecies of haemoflagellate parasite, Trypanosoma brucei and transmitted by tsetse flies. Progress made in HAT ...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
